Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
FKZUETMLLHIIQA
|
8.4 | Ki | 3 | — | |
KKUQFANVMIQQGN
|
8.4 | IC50 | 2 | — | |
XZPRJBUBLHJZRS
|
8.4 | Ki | 3 | — | |
KMXBENJAVFIELJ
|
8.4 | IC50 | 3 | — | |
LFAHWMOZPVCJAY
|
8.4 | Kd | 8 | — | |
NMTZYQHZJFNBJB
|
8.4 | IC50 | 2 | — | |
OMCKZGKVNHOOFJ
|
8.4 | Ki | 3 | — | |
AYSFEKIVJXIJTM
|
8.4 | IC50 | 8 | — | |
BVNDJEHETZIZCV
|
8.4 | Ki | 5 | — | |
CJOZQFXWSCXETF
|
8.4 | IC50 | 2 | — | |
DMFMPEWLXMKYKK
|
8.4 | IC50 | 4 | — | |
FNTXTLNLTQPVBJ
|
8.4 | IC50 | 6 | — | |
GHAZVJQMLWOQLP
|
8.4 | Ki | 17 | — | |
GIGLFCYZHQSMBV
|
8.4 | IC50 | 2 | — | |
GTWJSUYVWGBQFX
|
8.4 | IC50 | 2 | — | |
HMUYSTSHIXJVRO
|
8.4 | IC50 | 5 | — | |
HSFYCTPGOPYGHQ
|
8.4 | IC50 | 2 | — | |
IMHKMKWSWHFKTM
|
8.4 | Ki | 13 | — | |
JIQRMBNAYWCUEG
|
8.4 | IC50 | 3 | — | |
KAZJIBCOYQRDGG
|
8.4 | Ki | 16 | — | |
OLUKILHGKRVDCT
|
8.4 | IC50 | 44 | Yes | |
QTTYXMRMIOCNGZ
|
8.4 | Ki | 3 | — | |
QUTRBEMNJLJANB
|
8.4 | IC50 | 4 | — | |
UZFPGFONVYFSRR
|
8.4 | Ki | 16 | — | |
XFTCKLNUSFOJAU
|
8.4 | IC50 | 3 | Yes | |
DHUZGFWZXDRLHY
|
8.4 | Ki | 3 | — | |
FOIHPBSHQSHIIT
|
8.4 | IC50 | 2 | — | |
OXEXOPRYGJGEFF
|
8.4 | IC50 | 2 | — | |
QBXUCZWIDBSQSN
|
8.4 | Ki | 3 | — | |
GCQDVAUTFJHBKP
|
8.4 | IC50 | 2 | — | |
KBYBZFDPEVMQPA
|
8.4 | Ki | 3 | — | |
OKGXRGDRQODOSG
|
8.4 | Ki | 3 | — | |
CWSPSVWUDNKYOG
|
8.4 | Ki | 3 | — | |
HVIKGCPTKADTTQ
|
8.4 | IC50 | 2 | — | |
GCNSUXMONRYRHL
|
8.4 | IC50 | 4 | Yes | |
KEYFECUQJZMQPL
|
8.4 | Ki | 4 | — | |
UWQKULXATKCNBV
|
8.4 | IC50 | 4 | — | |
XDFFVEKPUCXBOI
|
8.4 | IC50 | 2 | — | |
ZKLIZNFRTSVUNN
|
8.4 | Ki | 3 | — | |
IGJFKRWDBQKNRJ
|
8.3 | IC50 | 2 | — | |
OKNZZSFQOJYPBN
|
8.3 | Ki | 3 | — | |
ATMYMANOXIJSDR
|
8.3 | IC50 | 2 | — | |
IQZQCERNFAXKFQ
|
8.3 | IC50 | 3 | — | |
QNUACCMSCPINIY
|
8.3 | IC50 | 2 | — | |
MAEBGEQKDJPVBH
|
8.3 | IC50 | 2 | — | |
OLKIZDOBETVOFT
|
8.3 | IC50 | 2 | — | |
WQUSEPBJMLQZJS
|
8.3 | IC50 | 2 | — | |
FHCSBLWRGCOVPT
|
8.3 | Ki | 2 | — | |
UHPQNSPVZNHDHX
|
8.3 | Ki | 3 | — | |
ZKLIZNFRTSVUNN
|
8.3 | Ki | 3 | — |